Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Gennex Laboratories Ltd
Your Vote -
Buy
70.00%
Hold
10.00%
Sell
20.00%
70.00%
20 users have voted
Option Chain
Analyzes market sentiment, predicts Gennex Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Gennex Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Gennex Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Gennex Laboratories - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regul
-
Gennex Laboratories - Integrated Filing (Financial)
-
Gennex Laboratories Q3 net profit jumps 59.47% at Rs 4.21 cr
-
Gennex Laboratories - Unaudited Financial Results For Quarter And Nine Months Ended December 31, 2024
-
Gennex Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited
-
Gennex Laboratories - Statement Of Deviation Or Variation In The Use Of Proceeds Pursuant To Regulations 32 Of The SEBI (List
-
Gennex Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Gennex Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Gennex Laboratories Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 171.6065 | 80.0009 | 54.1213 | 47.2541 | 40.8383 |
Liabilities | 171.6065 | 80.0009 | 54.1213 | 47.2541 | 40.8383 |
Equity | 22.7447 | 18.0192 | 12.6503 | 12.6503 | 12.6503 |
Gross Profit | 12.4188 | 4.5829 | 5.378 | 6.5333 | 3.2471 |
Net Profit | 11.7979 | 4.5589 | 3.9232 | 4.0381 | 1.8563 |
Cash From Operating Activities | -33.4279 | -14.4505 | 6.6361 | -1.4371 | -1.6712 |
NPM(%) | 17.66 | 7 | 6.4 | 6.76 | 3.33 |
Revenue | 66.7987 | 65.0981 | 61.2137 | 59.6489 | 55.6173 |
Expenses | 54.3798 | 60.5151 | 55.8357 | 53.1156 | 52.3701 |
ROE(%) | 6.53 | 2.52 | 2.17 | 2.23 | 1.02 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Gennex Laboratories Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 827.00 | 0.24 | 11.74 | 7.44 | 1321.50 | 1.38 |
Lotus Eye Hospital and Institute Ltd | 80.93 | 0.65 | 339.54 | 27.12 | 14.01 | 0.61 |
Bharat Immunological and Biologicals Corporation Ltd | 22.70 | -0.92 | 0.00 | 56.31 | -39.50 | 0.00 |
Astec Lifesciences Ltd | 672.50 | -1.84 | 0.00 | 25.57 | -687.11 | 0.00 |
Company Info
PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June, 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March, 1990. The Company has been promoted by Pharmasia Limited, a Company registered under the Companies Act, 1956 and having its registered office at 49, BHEL Enclave, Akbar Road, Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited, a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited, located at 133, Bollaram, Medak Dist., in an auction in January, 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off. The Company became a Deemed Public Limited Company with effect from 6th February, 1993 as per the provisions of section 43A(1) of the Companies Act, 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November, 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 15th February, 1995. The Company's name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 22nd February, 1995. Mr.Vinod Baid & his associates, acquired the entire holding of Pharmasia Limited amounting to 1,40,018 shares at their face value, (the consideration for which has been paid in cash) in November, 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs. The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act, 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees. At the time of take-over, the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover, the company under the new management had taken up the implementation of the project in right earnest. The products were identified, additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September, 1995 and the Commercial Production has already commenced. 2007 - Company name has been changed from Prudential Pharmaceuticals Ltd to Gennex Laboratories Ltd. 2009 -Company has splits its Face value of Shares from Rs 10 to Re 1. 2022 -The company issued rights shares of Rs. 1 in the ratio of 1:2 at a premium of Rs. 5 per share.
PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June, 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March, 1990. The Company has been promoted by Pharmasia Limited, a Company registered under the Companies Act, 1956 and having its registered office at 49, BHEL Enclave, Akbar Road, Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited, a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited, located at 133, Bollaram, Medak Dist., in an auction in January, 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off. The Company became a Deemed Public Limited Company with effect from 6th February, 1993 as per the provisions of section 43A(1) of the Companies Act, 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November, 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 15th February, 1995. The Company's name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies, Andhra Pradesh, on 22nd February, 1995. Mr.Vinod Baid & his associates, acquired the entire holding of Pharmasia Limited amounting to 1,40,018 shares at their face value, (the consideration for which has been paid in cash) in November, 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs. The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act, 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees. At the time of take-over, the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover, the company under the new management had taken up the implementation of the project in right earnest. The products were identified, additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September, 1995 and the Commercial Production has already commenced. 2007 - Company name has been changed from Prudential Pharmaceuticals Ltd to Gennex Laboratories Ltd. 2009 -Company has splits its Face value of Shares from Rs 10 to Re 1. 2022 -The company issued rights shares of Rs. 1 in the ratio of 1:2 at a premium of Rs. 5 per share.
Read More
Parent Organisation
Gennex Laboratories Ltd.
Founded
29/03/1990
Managing Director
Mr.Arihant Baid
NSE Symbol
FAQ
The current price of Gennex Laboratories Ltd is
The 52-week high for Gennex Laboratories Ltd is
The market capitalization of Gennex Laboratories Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Gennex Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Gennex Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gennex Laboratories Ltd shares.
The CEO of Gennex Laboratories Ltd is Mr.Arihant Baid, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.